Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.54 |
| ▸ | F2 | P00734 | 5/20 | 0.53 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.51 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.49 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 2/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31127558 | 0.91 | F2 (0.60) | OPRM1F2C5AR1OPRD1ACE | |
| SCHEMBL29473717 | 0.90 | CALCR (0.57) | OPRM1F2C5AR1OPRD1APLNR | |
| SCHEMBL31127566 | 0.88 | OPRM1 (0.60) | OPRM1F2C5AR1OPRD1 | |
| SCHEMBL31573971 | 0.88 | OPRM1 (0.52) | OPRM1F2C5AR1OPRD1AGTR1 | |
| SCHEMBL30974277 | 0.88 | C5AR1 (0.62) | OPRM1F2C5AR1APLNR | |
| SCHEMBL29461549 | 0.88 | F2 (0.60) | OPRM1F2OPRD1 | |
| SCHEMBL29630353 | 0.87 | F2 (0.55) | OPRM1F2C5AR1OPRD1APLNR | |
| SCHEMBL30974009 | 0.87 | C5AR1 (0.62) | OPRM1F2C5AR1OPRD1APLNR | |
| SCHEMBL31041698 | 0.86 | CALCR (0.49) | OPRM1F2C5AR1APLNR | |
| SCHEMBL30310199 | 0.86 | OPRK1 (0.55) | OPRM1F2OPRD1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4216992-A1 | PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION | DBV Technologies (FR) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022063990-A1 | PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION | DBV TECHNOLOGIES (FR) | 2022-03-31 | — | — | WO | disclosed |